CancerDetect™ - Oral & Throat
First at-home early detection test kit for throat and oral cancer
Company profile
Company profile
Viome Life Sciences is a health and longevity company that bridges the gap between scientific advancements and individual well-being through artificial intelligence and advanced RNA technology. The company's mission is to uncover the root causes of chronic diseases, cancer, and aging in order to prevent, diagnose early, and reverse them. Viome offers at-home microbiome health testing kits that analyze over 100,000 biomarkers from gut, oral, and cellular samples. Using proprietary AI technology, Viome examines not just which microorganisms are present, but how they're actively behaving and impacting health in real-time. The company's flagship Full Body Intelligence Test provides over 70 health scores including BioAge and Inflammation scores, along with 370+ personalized food recommendations. Results are delivered within 2-3 weeks through a personalized app that connects microbiome activity to digestive health, energy, brain health, immune function, weight management, sleep quality, and cardiovascular health. Beyond testing, Viome offers personalized products including Precision Supplements, VRx My-Biotics formulas for gut and oral health, and custom toothpaste formulations. The company's approach considers individual test results, over 20,000 clinical study references, and reported health conditions to create targeted recommendations that address underlying causes rather than just symptoms. With over 1 million tests analyzed, Viome serves consumers directly as well as through healthcare providers, employers, and distribution partners. All testing is conducted in CLIA-certified laboratories, and products are HSA/FSA eligible.
Company description Viome official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Hybrid · Other deployment with recorded integration context.
Company milestones
Launch of CancerDetect Oral & Throat test - first at-home early detection throat and oral cancer test kit. Over 1 million tests analyzed milestone reached.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
First at-home early detection test kit for throat and oral cancer
Advanced at-home test analyzing gut, cellular, and oral microbiome for holistic health insights
Foundational at-home test for improving gut health with 25+ health scores
At-home test focused on oral microbiome health with 15 health scores
AI-powered personalized supplements based on individual test results
Personalized prebiotics and probiotics for gut health
Personalized oral lozenges for oral microbiome health
Personalized oral care products powered by precision AI
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Microorganisms · Apr 7, 2026
Altered gut microbial functional pathways in people with irritable bowel syndrome enable precision health insights.BMC gastroenterology · Nov 20, 2025
Fecal Microbiome in Women With Fibromyalgia: Functional Composition and Symptom Correlations.ACR open rheumatology · Sep 1, 2025
Characterisation of the Oral Microbiome in Women With Fibromyalgia: An Observational Case-Control Study.European journal of pain (London, England) · Jul 1, 2025
Preparation of robust synthetic control samples and their use in a metatranscriptomic clinical test.Scientific reports · Mar 24, 2025
An association between poor oral health, oral microbiota, and pain identified in New Zealand women with central sensitisation disorders: a prospective clinical study.Frontiers in pain research (Lausanne, Switzerland) · Jan 1, 2025
Clinical validation
NCT07786818 · Sponsor · RECRUITING
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
including BioAge Score and Inflammation Score from Full Body Intelligence Test
tailored to individual biology and microbiome activity
from gut, oral, and cellular samples
to provide insights into microbiome health optimization
for toothpaste formulation when used twice daily
Microbiome testing and personalized health recommendations
Over 1 million tests analyzed
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Viome's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI to optimize metabolic health, provide personalized nutrition recommendations, or analyze metabolic responses to food for generally healthy or non-diabetic populations. Emphasizes wellness, performance optimization, and preventive health rather than management of a diagnosed disease.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.